TherageniX and University of Nottingham awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration

Funding from Innovate UK’s Transforming Medicines Manufacturing program supporting innovative technologies for intracellular drug delivery.

AI outperforms radiologists in brain tumor diagnosis

As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that may even surpass human expertise. In the field

October 1, 2024

AbbVie’s $10B ImmunoGen deal was won by paying $7 a share over a rival bidder’s offer, SEC filings show

In ImmunoGen’s months-long negotiations to sell itself, AbbVie came in relatively late but managed to seal the deal with an offer much higher than rival

December 27, 2023

Testosterone therapy reduces gender dysphoria, depression and suicidality in trans adults

Receiving rapid access to testosterone therapy reduced feelings of gender dysphoria and led to a clinically significant reduction in depression as well as a 50%

June 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.